Epinoma unlocks deep insights into the epigenome with EpiAmp, the first methyl-preserving amplification technology. They focus on harnessing the power of epigenetics to drive new paradigms for disease detection and treatment, develop precision epigenetic medicine, and accelerate biopharma development by comparing healthy and diseased epigenetic states.